NARA — Pangenomic Health Balance Sheet
0.000.00%
- CA$21.13m
- CA$21.13m
- 11
- 17
- 72
- 24
Annual balance sheet for Pangenomic Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.038 | 1.35 | 0.089 | 0.013 | 0.001 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.108 | 0.041 | 0.192 | 0.042 | 0.031 |
Prepaid Expenses | |||||
Total Current Assets | 0.147 | 1.67 | 0.484 | 0.061 | 0.037 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0.025 | 0.02 | 0.011 | 0.002 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Total Assets | 0.147 | 2.58 | 0.504 | 0.071 | 0.039 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.136 | 0.334 | 0.719 | 2.22 | 2.44 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.136 | 0.334 | 0.719 | 2.22 | 2.44 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.011 | 2.24 | -0.215 | -2.14 | -2.41 |
Total Liabilities & Shareholders' Equity | 0.147 | 2.58 | 0.504 | 0.071 | 0.039 |
Total Common Shares Outstanding |